Search research articles
Contact Us
Filters
Showing results (51-60 of 297) with videos related to
Page
of 30
Sort By:
Science Translational Medicine
|
May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia
David Wu, Anna Sherwood, Jonathan R Fromm, et al.
Human Heredity
|
August 7, 2014
A new system identification approach to identify genetic variants in sequencing studies for a binary phenotype
Guolian Kang, Wenjian Bi, Yanlong Zhao, et al.
Pediatric Blood & Cancer
|
May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
Blood Advances
|
August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at Diagnosis
Mathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Nature
|
November 4, 2016
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment
Lei Dong, Wen-Mei Yu, Hong Zheng, et al.
Leukemia
|
June 10, 2018
Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells
Sarah K Tasian, Jessica A Casas, David Posocco, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia
Santhosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Blood
|
February 24, 2006
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
Mignon L Loh, Meredith A Goldwasser, Lewis B Silverman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2014
Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH
David Wu, Ryan O Emerson, Anna Sherwood, et al.
Page
of 30
Search research articles
Search
Showing results (51-60 of 297) with videos related to
Sort By:
Page
of 30
Science Translational Medicine
|
May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia
David Wu, Anna Sherwood, Jonathan R Fromm, et al.
Human Heredity
|
August 7, 2014
A new system identification approach to identify genetic variants in sequencing studies for a binary phenotype
Guolian Kang, Wenjian Bi, Yanlong Zhao, et al.
Pediatric Blood & Cancer
|
May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
Blood Advances
|
August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at Diagnosis
Mathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Nature
|
November 4, 2016
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment
Lei Dong, Wen-Mei Yu, Hong Zheng, et al.
Leukemia
|
June 10, 2018
Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells
Sarah K Tasian, Jessica A Casas, David Posocco, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia
Santhosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Blood
|
February 24, 2006
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
Mignon L Loh, Meredith A Goldwasser, Lewis B Silverman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2014
Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH
David Wu, Ryan O Emerson, Anna Sherwood, et al.
Page
of 30